Insmed officer William Lewis plans $1.26M share sale
The notice also reports seven earlier sales by Lewis, including a 25,564-share sale on May 18, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Insmed Inc (INSM) officer William Lewis reported plans to sell 10,699 common shares, with an aggregate market value of $1,256,029 and an approximate sale date of July 9, 2026. The shares are listed as acquired from the issuer through stock plan activity on July 9, 2026. A Rule 10b5-1 plan adoption or instruction date is listed as September 4, 2025.
Lewis’s listed prior sales ran from April 16 through June 25, 2026, and ranged from 6,515 to 25,564 shares, with gross proceeds per transaction ranging from $612,576 to $2,718,106.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Stock Plan Activity financial
Aggregate Market Value financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was William Lewis’s largest recent INSM sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.